Interleukin 6 As an Energy Allocator in Muscle Tissue

Overview

Journal Nat Metab

Publisher Springer Nature

Specialty Endocrinology

Date 2022 Feb 25

PMID 35210610

Authors

Timothy M Kistner

Bente K Pedersen

Daniel E Lieberman

Affiliations

Soon will be listed here.

Abstract

Extensive research has shown that interleukin 6 (IL-6) is a multifunctional molecule that is both proinflammatory and anti-inflammatory, depending on the context. Here, we combine an evolutionary perspective with physiological data to propose that IL-6's context-dependent effects on metabolism reflect its adaptive role for short-term energy allocation. This energy-allocation role is especially salient during physical activity, when skeletal muscle releases large amounts of IL-6. We predict that during bouts of physical activity, myokine IL-6 fulfills the three main characteristics of a short-term energy allocator: it is secreted from muscle in response to an energy deficit, it liberates somatic energy through lipolysis and it enhances muscular energy uptake and transiently downregulates immune function. We then extend this model of energy allocation beyond myokine IL-6 to reinterpret the roles that IL-6 plays in chronic inflammation, as well as during COVID-19-associated hyperinflammation and multiorgan failure.

Citing Articles

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.

Frailty and osteoporotic fractures represent mutual risks for each other with common physiological backgrounds.

Urano T, Kuroda T, Saito M, Shiraki M JBMR Plus. 2025; 9(4):ziaf009.

PMID: 40060918 PMC: 11886566. DOI: 10.1093/jbmrpl/ziaf009.

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.

Physical activity and exercise in liver cancer.

Chen H, Zhou H, Wu B, Lu H, Zhang J, Zhang Y Liver Res. 2025; 8(1):22-33.

PMID: 39959031 PMC: 11771262. DOI: 10.1016/j.livres.2024.03.001.

Il-6 signaling exacerbates hallmarks of chronic tendon disease by stimulating reparative fibroblasts.

Stauber T, Moschini G, Hussien A, Jaeger P, De Bock K, Snedeker J Elife. 2025; 12.

PMID: 39918402 PMC: 11805502. DOI: 10.7554/eLife.87092.

References

Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K . Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A. 1985; 82(16):5490-4. PMC: 391148. DOI: 10.1073/pnas.82.16.5490. View

Pedersen B, Akerstrom T, Nielsen A, Fischer C . Role of myokines in exercise and metabolism. J Appl Physiol (1985). 2007; 103(3):1093-8. DOI: 10.1152/japplphysiol.00080.2007. View

Costa M, Maehr T, Diaz-Rosales P, Secombes C, Wang T . Bioactivity studies of rainbow trout (Oncorhynchus mykiss) interleukin-6: effects on macrophage growth and antimicrobial peptide gene expression. Mol Immunol. 2011; 48(15-16):1903-16. DOI: 10.1016/j.molimm.2011.05.027. View

Geisterfer M, Richards C, Baumann M, Fey G, Gywnne D, Gauldie J . Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. Cytokine. 1993; 5(1):1-7. DOI: 10.1016/1043-4666(93)90017-y. View

Path G, Bornstein S, Gurniak M, Chrousos G, Scherbaum W, Hauner H . Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab. 2001; 86(5):2281-8. DOI: 10.1210/jcem.86.5.7494. View

Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S . The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011; 1813(5):878-88. DOI: 10.1016/j.bbamcr.2011.01.034. View

Lust J, Donovan K, Kline M, Greipp P, Kyle R, Maihle N . Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 1992; 4(2):96-100. DOI: 10.1016/1043-4666(92)90043-q. View

Wolf J, Waetzig G, Chalaris A, Reinheimer T, Wege H, Rose-John S . Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling. J Biol Chem. 2016; 291(31):16186-96. PMC: 4965567. DOI: 10.1074/jbc.M116.718551. View

Heink S, Yogev N, Garbers C, Herwerth M, Aly L, Gasperi C . Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T17 cells. Nat Immunol. 2016; 18(1):74-85. PMC: 5164931. DOI: 10.1038/ni.3632. View

10.

Ruderman N, Keller C, Richard A, Saha A, Luo Z, Xiang X . Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes. 2006; 55 Suppl 2:S48-54. DOI: 10.2337/db06-s007. View

11.

Fischer C . Interleukin-6 in acute exercise and training: what is the biological relevance?. Exerc Immunol Rev. 2007; 12:6-33. View

12.

Wang X, Bao W, Liu J, Ouyang Y, Wang D, Rong S . Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2012; 36(1):166-75. PMC: 3526249. DOI: 10.2337/dc12-0702. View

13.

Klover P, Zimmers T, Koniaris L, Mooney R . Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes. 2003; 52(11):2784-9. DOI: 10.2337/diabetes.52.11.2784. View

14.

Rotter V, Nagaev I, Smith U . Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003; 278(46):45777-84. DOI: 10.1074/jbc.M301977200. View

15.

Saini A, Faulkner S, Moir H, Warwick P, King J, Nimmo M . Interleukin-6 in combination with the interleukin-6 receptor stimulates glucose uptake in resting human skeletal muscle independently of insulin action. Diabetes Obes Metab. 2014; 16(10):931-6. DOI: 10.1111/dom.12299. View

16.

Ellingsgaard H, Hauselmann I, Schuler B, Habib A, Baggio L, Meier D . Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011; 17(11):1481-9. PMC: 4286294. DOI: 10.1038/nm.2513. View

17.

van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P . Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003; 88(7):3005-10. DOI: 10.1210/jc.2002-021687. View

18.

Timper K, Denson J, Steculorum S, Heilinger C, Engstrom-Ruud L, Wunderlich C . IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling. Cell Rep. 2017; 19(2):267-280. DOI: 10.1016/j.celrep.2017.03.043. View

19.

Lehrskov L, Lyngbaek M, Soederlund L, Legaard G, Ehses J, Heywood S . Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control. Cell Metab. 2018; 27(6):1201-1211.e3. DOI: 10.1016/j.cmet.2018.04.008. View

20.

Munoz-Canoves P, Scheele C, Pedersen B, Serrano A . Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?. FEBS J. 2013; 280(17):4131-48. PMC: 4163639. DOI: 10.1111/febs.12338. View